New research project to examine the role of microglia—immune cells in the brain—in determining risk for Alzheimer’s disease using cellular reprogramming.

The John Douglas French Alzheimer's Foundation has funded an important new research project under the direction of Justin Ichida, PhD, of the University of Southern California, Department of Stem Cell Biology and Regenerative Medicine. 

Learn More>

Bruce L. Miller, MD, Chief Medical Officer of The John Douglas French Alzheimer's Foundation, has been elected to the National Academy of Medicine. 

Election to the National Academy of Medicine is one of the highest honors in the fields of health and medicine.

Learn More>

JDFAF has just funded a breakthrough research project integrating the expertise and resources of researchers at three University of California campuses.

The new study employs the latest genomic technologies and holds the potential of gaining important new insights into the role of genetics in the development of Alzheimer’s disease.

Learn More>